Lamm WLG, Fernández CA, Vivieros EJM, Morales MG, Mata MP, Pacheco GC, Calderón FF

Language: Spanish
References: 18
Page: 198-205
PDF size: 329.31 Kb.

ABSTRACT

Introduction: Risk factors for the development of penile carcinoma includes deficient hygiene of the prepuce that enhance chronic and recurrent infections and inflammatory response. Inguinal and pelvic lymph nodes, tumor grade and extension of the disease have a profound influence in overall survival.
Matherial and methods: 29 patients with penile carcinoma were evaluated for 24 months of survival function. Tumor grading, stage, number and presence of unilateral or bilateral inguinal and pelvic lymph nodes, as well as initial and adjuvant response to treatment were assessed.
Results: 93% (27) were epidermoid carcinomas with an ulcerative presentation (72%) localized to the penis glans (79%). We found that T3 stage, grade 3, bilateral or more than 4 palpable persistent inguinal and pelvic lymph nodes had a profound impact over the 24 months of survival function.
Conclusions: Our results are similar to those found on medical literature. The prolonged evolution time of the disease explains why most of our patients have invasive cancer at the moment of diagnosis.

REFERENCES

1. Vatanasapt V, Martin N, Sriplung H et al. Cancer incidence in Thailand, 1988-1991. Cancer Epidemiol Biomarkers Prev. 1995;4:475-83.

2. Frisch M, Goodman MT. Human papillomavirus-associated carcinomas in Hawaii and the mainland U.S. Cancer. 2000;88:1464-9.

3. Sufrin G, Huben R. Benign and malignant lesions of the penis. In Gillenwater JY (ed): Adult and Pediatric Urology, 2nd ed. Chicago, Year Book, 1991:1997-2042.

4. Theodorescu D, Russo P, Zhang ZF et al. Outcomes of initial surveillance of invasive squamous cell carcinoma of the penis and negative nodes. J Urol. 1996;155:1626-31.

5. Vapnek JM, Hricak H, Carroll PR. Recent advances in imaging studies for staging of penile and urethral carcinoma. Urol Clin North Am. 1992;19:257-66.

6. Vatanasapt V, Martin N, Sriplung MH et al. Cancer incidence in Thailand, 1988-1991. Cancer Epidemiol Biomarkers Prev 1995;4:47583.

7. Johnson DE, Fuerst DE, Ayala AG. Carcinoma of the penis. Experience in 153 cases. Urology. 1973;1:404-8.

8. Whitmore WF: Tumors of the penis, urethra, scrotum, and testes. In Campbell MF, Harrison HH (eds): Urology, 3rd ed. Philadelphia, WB Saunders, 1970:1129-1190.

9. Villavicencio H, Rubio-Briones J, Regalado R et al. Grade, local stage and growth pattern as prognostic factors in carcinoma of the penis. Eur Urol. 1997; 32:442-7.

10. Jamieson NV, Bullock KN, Barker TH. Adenosquamous carcinoma of the penis associated with balanitis xerotica obliterans. J Urol. 1986;58:730-1.

11. Solsona E, Iborra I, Ricos JV et al. Corpus cavernosum invasion and tumor grade in the prediction of lymph node condition in penile carcinoma. Eur Urol. 1992;22:115-8.

12. Heyns CF, Van Vollenhoven P, Steenkamp JW et al Carcinoma of the penis—appraisal of a modified tumor-staging system. Br J Urol. 1997;80:307-12.

13. Skinner DG, Leadbetter WF, Kelley SB. The surgical management of squamous cell carcinoma of the penis. J Urol. 1972;107:273-7.

14. Shiraki IW: Parameatal cysts of the glans penis. A report of nine cases. J Urol. 1975;114:544-548.

15. Seixas ALC, Ornellas AA, Marota A et al. Verrucous carcinoma of the penis: Retrospective analysis of 32 cases. J Urol. 1994;152:1476-1479.

16. Griffiths TR, Mellon JK. Human papillomavirus and urological tumours: I. Basic science and role in penile cancer. BJU Int. 1999;84:579-86.

17. Riveros M, Garcia R, Cabanas R. Lymphadenography of the dorsal lymphatics of the penis. Technique and results. Cancer. 1967;20:2026-31.

18. Ravi R. Correlation between the extent of nodal involvement and survival following groin dissection for carcinoma of the penis. Br J Urol. 1993b;72:817-819.